Selective COX-2 inhibitors: where do we go from here?
- PMID: 18922571
- DOI: 10.1016/S0140-6736(08)61491-9
Selective COX-2 inhibitors: where do we go from here?
Comment on
-
Cardiovascular events associated with rofecoxib: final analysis of the APPROVe trial.Lancet. 2008 Nov 15;372(9651):1756-64. doi: 10.1016/S0140-6736(08)61490-7. Epub 2008 Oct 14. Lancet. 2008. PMID: 18922570 Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
